Review Outlines How RNA Therapeutics Are Expanding Modern Cancer Immunotherapy Options
A comprehensive review analyzes how synthetic mRNA, oligonucleotides, and aptamers are advancing clinical oncology treatments beyond conventional immune therapies.

















